Home/Investors/Public Shareholders (HKEX)

Public Shareholders (HKEX)

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$4.2B
Focus Areas
6
Top Stage
commercial

Portfolio Companies

CompanyValuation
Peijia Medical$3.6B
Sirnaomics$603.3M